CG200745, an HDAC inhibitor, induces anti-tumour effects in cholangiocarcinoma cell lines targeting the Hippo pathway

ABSTRACT: The effects of CG200745 on SNU-1196 and SNU-1196/GR (gemcitabine resistant cell line) were assessed by cDNA and miRNA microarray analyses after 24 h of treatment.

ORGANISM(S): Homo sapiens

SUBMITTER: Dawoon Jung 

PROVIDER: E-MTAB-5733 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress